The Effectiveness of Oral Dexamethasone for Acute Bronchiolitis

Status Completed

Clinical Trial Summary

This study will compare a single dose of oral dexamethasone to placebo in a multicenter, randomized, double blind trial of infants aged 2 to 12 months with first-time bronchiolitis (defined as wheezing within 7 days of onset). This is given as additional therapy beyond any other routine therapy used at that center. No current standard therapy is withheld, and no additional tests or other treatments are part of the study.The primary hypothesis is that dexamethasone will be more effective than placebo in preventing hospital admission. The secondary hypotheses are that dexamethasone will decrease respiratory scores and possibly the duration of the disease when compared to placebo, and that dexamethasone will be as safe and as well tolerated as placebo.

Clinical Trial Description

Bronchiolitis is the most common lower respiratory infection in infants, and the respiratory condition leading to the most hospital admissions in young children. It is also probably the most common serious illness of childhood lacking evidence-based treatment. Evidence both for and against the effectiveness of corticosteroids such as dexamethasone has been published. Editorials, expert reviews, and a recent report from the Agency for Healthcare Research and Quality recommend a study such as this one.

Patients will be drawn from the emergency departments at participating medical centers in the Pediatric Emergency Care Applied Research Network, created by the Emergency Medical Services for Children program and the Maternal and Child Health Bureau of the Health Resources and Services Administration to study health problems of high acuity and high incidence in children.

Comparisons: The primary outcome (hospital admission after 4 hours of ED observation) and secondary outcomes will be compared between treatment and placebo groups. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00119002
Study type	Interventional
Source	University of Utah
Contact
Status	Completed
Phase	Phase 4
Start date	January 2004
Completion date	April 2006

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04989114` - Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis	N/A
Recruiting	`NCT04287959` - SWISH Trial (Strategies for Weaning Infants on Supportive High Flow)	N/A
Not yet recruiting	`NCT01618175` - Home Oxygen Treatment of Childhood Acute Bronchiolitis	N/A
Completed	`NCT01247064` - Hypertonic Saline for Acute Bronchiolitis	Phase 4
Completed	`NCT03062917` - Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis	N/A
Recruiting	`NCT06030505` - Effectiveness of Nirsevimab in Children Hospitalised With RSV Bronchiolitis
Completed	`NCT02571517` - Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis	Phase 4
Completed	`NCT02853838` - Chest Physiotherapy in Infants Between 0 and 12 Months Old With Acute Bronchiolitis SRV(+)	N/A
Terminated	`NCT03252119` - High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis	N/A
Active, not recruiting	`NCT04740294` - Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis	Phase 2/Phase 3
Terminated	`NCT03959384` - Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age	Phase 3
Terminated	`NCT04221087` - Steroid Use in Non-RSV Bronchiolitis	Phase 4
Recruiting	`NCT04764929` - Pediatric Helmet CPAP Pilot Study	N/A
Completed	`NCT00122785` - Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.